Cargando…

Application of Indocyanine Green Fluorescence Imaging in Assisting Biopsy of Musculoskeletal Tumors

SIMPLE SUMMARY: Biopsy and pathological diagnosis are the gold standard for the diagnosis of bone and soft tissue tumors. However, in the existing biopsy process, due to the heterogeneity of tumors, we find that there is still a high failure rate. As clinicians in the field of cancer, we hope to int...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Siyuan, Zhong, Ang, Lei, Jun, Deng, Zhouming, Zhu, Xiaobin, Wei, Renxiong, Huang, Huayi, Chen, Zhenyi, Cai, Lin, Xie, Yuanlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136962/
https://www.ncbi.nlm.nih.gov/pubmed/37190330
http://dx.doi.org/10.3390/cancers15082402
Descripción
Sumario:SIMPLE SUMMARY: Biopsy and pathological diagnosis are the gold standard for the diagnosis of bone and soft tissue tumors. However, in the existing biopsy process, due to the heterogeneity of tumors, we find that there is still a high failure rate. As clinicians in the field of cancer, we hope to introduce the optical biopsy of bone and soft tissue tumors through the research into near-infrared fluorescence imaging in cancer. We utilize the accumulation effect of indocyanine green in tumors and use optical biopsy to further improve the success and reduce the failure rate of skeletal muscle tumor biopsy. ABSTRACT: (1) Background: Biopsies are the gold standard for the diagnosis of musculoskeletal tumors. In this study, we aimed to explore whether indocyanine green near-infrared fluorescence imaging can assist in the biopsy of bone and soft tissue tumors and improve the success rate of biopsy. (2) Method: We recruited patients with clinically considered bone and soft tissue tumors and planned biopsies. In the test group, indocyanine green (0.3 mg/kg) was injected. After identifying the lesion, a near-infrared fluorescence camera system was used to verify the ex vivo specimens of the biopsy in real time. If the biopsy specimens were not developed, we assumed that we failed to acquire lesions, so the needle track and needle position were adjusted for the supplementary biopsy, and then real-time imaging was performed again. Finally, we conducted a pathological examination. In the control group, normal biopsy was performed. (3) Results: The total diagnosis rate of musculoskeletal tumors in the test group was 94.92% (56/59) and that in the control group was 82.36% (42/51). In the test group, 14 cases were not developed, as seen from real-time fluorescence in the core biopsy, and then underwent the supplementary biopsy after changing the puncture direction and the location of the needle channel immediately, of which 7 cases showed new fluorescence. (4) Conclusions: Using the near-infrared fluorescence real-time development technique to assist the biopsy of musculoskeletal tumors may improve the accuracy of core biopsy and help to avoid missed diagnoses, especially for some selected tumors.